Cargando…

A likely unavoidable clinical scenario during treatment for venous thromboembolism complicated with severe immune thrombocytopenia: A case report

Patients with immune thrombocytopenia have increased risks of bleeding and thrombosis. The acute‐phase treatment for venous thromboembolism complicated with severe immune thrombocytopenia involves a “platelet dilemma” in therapeutic decision‐making.

Detalles Bibliográficos
Autores principales: Takeuchi, Takaya, Matsuura, Yunosuke, Yamamura, Yoshimasa, Ohkusu, Momoko, Koyama, Shohei, Kawaguchi, Takeshi, Akaki Nagayasu, Mayumi, Komatsu, Hiroyuki, Okayama, Akihiko, Ishikawa, Tetsunori, Atsumi, Tatsuya, Kitamura, Kazuo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8449094/
https://www.ncbi.nlm.nih.gov/pubmed/34567553
http://dx.doi.org/10.1002/ccr3.4805
_version_ 1784569361010262016
author Takeuchi, Takaya
Matsuura, Yunosuke
Yamamura, Yoshimasa
Ohkusu, Momoko
Koyama, Shohei
Kawaguchi, Takeshi
Akaki Nagayasu, Mayumi
Komatsu, Hiroyuki
Okayama, Akihiko
Ishikawa, Tetsunori
Atsumi, Tatsuya
Kitamura, Kazuo
author_facet Takeuchi, Takaya
Matsuura, Yunosuke
Yamamura, Yoshimasa
Ohkusu, Momoko
Koyama, Shohei
Kawaguchi, Takeshi
Akaki Nagayasu, Mayumi
Komatsu, Hiroyuki
Okayama, Akihiko
Ishikawa, Tetsunori
Atsumi, Tatsuya
Kitamura, Kazuo
author_sort Takeuchi, Takaya
collection PubMed
description Patients with immune thrombocytopenia have increased risks of bleeding and thrombosis. The acute‐phase treatment for venous thromboembolism complicated with severe immune thrombocytopenia involves a “platelet dilemma” in therapeutic decision‐making.
format Online
Article
Text
id pubmed-8449094
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-84490942021-09-24 A likely unavoidable clinical scenario during treatment for venous thromboembolism complicated with severe immune thrombocytopenia: A case report Takeuchi, Takaya Matsuura, Yunosuke Yamamura, Yoshimasa Ohkusu, Momoko Koyama, Shohei Kawaguchi, Takeshi Akaki Nagayasu, Mayumi Komatsu, Hiroyuki Okayama, Akihiko Ishikawa, Tetsunori Atsumi, Tatsuya Kitamura, Kazuo Clin Case Rep Case Report Patients with immune thrombocytopenia have increased risks of bleeding and thrombosis. The acute‐phase treatment for venous thromboembolism complicated with severe immune thrombocytopenia involves a “platelet dilemma” in therapeutic decision‐making. John Wiley and Sons Inc. 2021-09-18 /pmc/articles/PMC8449094/ /pubmed/34567553 http://dx.doi.org/10.1002/ccr3.4805 Text en © 2021 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Takeuchi, Takaya
Matsuura, Yunosuke
Yamamura, Yoshimasa
Ohkusu, Momoko
Koyama, Shohei
Kawaguchi, Takeshi
Akaki Nagayasu, Mayumi
Komatsu, Hiroyuki
Okayama, Akihiko
Ishikawa, Tetsunori
Atsumi, Tatsuya
Kitamura, Kazuo
A likely unavoidable clinical scenario during treatment for venous thromboembolism complicated with severe immune thrombocytopenia: A case report
title A likely unavoidable clinical scenario during treatment for venous thromboembolism complicated with severe immune thrombocytopenia: A case report
title_full A likely unavoidable clinical scenario during treatment for venous thromboembolism complicated with severe immune thrombocytopenia: A case report
title_fullStr A likely unavoidable clinical scenario during treatment for venous thromboembolism complicated with severe immune thrombocytopenia: A case report
title_full_unstemmed A likely unavoidable clinical scenario during treatment for venous thromboembolism complicated with severe immune thrombocytopenia: A case report
title_short A likely unavoidable clinical scenario during treatment for venous thromboembolism complicated with severe immune thrombocytopenia: A case report
title_sort likely unavoidable clinical scenario during treatment for venous thromboembolism complicated with severe immune thrombocytopenia: a case report
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8449094/
https://www.ncbi.nlm.nih.gov/pubmed/34567553
http://dx.doi.org/10.1002/ccr3.4805
work_keys_str_mv AT takeuchitakaya alikelyunavoidableclinicalscenarioduringtreatmentforvenousthromboembolismcomplicatedwithsevereimmunethrombocytopeniaacasereport
AT matsuurayunosuke alikelyunavoidableclinicalscenarioduringtreatmentforvenousthromboembolismcomplicatedwithsevereimmunethrombocytopeniaacasereport
AT yamamurayoshimasa alikelyunavoidableclinicalscenarioduringtreatmentforvenousthromboembolismcomplicatedwithsevereimmunethrombocytopeniaacasereport
AT ohkusumomoko alikelyunavoidableclinicalscenarioduringtreatmentforvenousthromboembolismcomplicatedwithsevereimmunethrombocytopeniaacasereport
AT koyamashohei alikelyunavoidableclinicalscenarioduringtreatmentforvenousthromboembolismcomplicatedwithsevereimmunethrombocytopeniaacasereport
AT kawaguchitakeshi alikelyunavoidableclinicalscenarioduringtreatmentforvenousthromboembolismcomplicatedwithsevereimmunethrombocytopeniaacasereport
AT akakinagayasumayumi alikelyunavoidableclinicalscenarioduringtreatmentforvenousthromboembolismcomplicatedwithsevereimmunethrombocytopeniaacasereport
AT komatsuhiroyuki alikelyunavoidableclinicalscenarioduringtreatmentforvenousthromboembolismcomplicatedwithsevereimmunethrombocytopeniaacasereport
AT okayamaakihiko alikelyunavoidableclinicalscenarioduringtreatmentforvenousthromboembolismcomplicatedwithsevereimmunethrombocytopeniaacasereport
AT ishikawatetsunori alikelyunavoidableclinicalscenarioduringtreatmentforvenousthromboembolismcomplicatedwithsevereimmunethrombocytopeniaacasereport
AT atsumitatsuya alikelyunavoidableclinicalscenarioduringtreatmentforvenousthromboembolismcomplicatedwithsevereimmunethrombocytopeniaacasereport
AT kitamurakazuo alikelyunavoidableclinicalscenarioduringtreatmentforvenousthromboembolismcomplicatedwithsevereimmunethrombocytopeniaacasereport
AT takeuchitakaya likelyunavoidableclinicalscenarioduringtreatmentforvenousthromboembolismcomplicatedwithsevereimmunethrombocytopeniaacasereport
AT matsuurayunosuke likelyunavoidableclinicalscenarioduringtreatmentforvenousthromboembolismcomplicatedwithsevereimmunethrombocytopeniaacasereport
AT yamamurayoshimasa likelyunavoidableclinicalscenarioduringtreatmentforvenousthromboembolismcomplicatedwithsevereimmunethrombocytopeniaacasereport
AT ohkusumomoko likelyunavoidableclinicalscenarioduringtreatmentforvenousthromboembolismcomplicatedwithsevereimmunethrombocytopeniaacasereport
AT koyamashohei likelyunavoidableclinicalscenarioduringtreatmentforvenousthromboembolismcomplicatedwithsevereimmunethrombocytopeniaacasereport
AT kawaguchitakeshi likelyunavoidableclinicalscenarioduringtreatmentforvenousthromboembolismcomplicatedwithsevereimmunethrombocytopeniaacasereport
AT akakinagayasumayumi likelyunavoidableclinicalscenarioduringtreatmentforvenousthromboembolismcomplicatedwithsevereimmunethrombocytopeniaacasereport
AT komatsuhiroyuki likelyunavoidableclinicalscenarioduringtreatmentforvenousthromboembolismcomplicatedwithsevereimmunethrombocytopeniaacasereport
AT okayamaakihiko likelyunavoidableclinicalscenarioduringtreatmentforvenousthromboembolismcomplicatedwithsevereimmunethrombocytopeniaacasereport
AT ishikawatetsunori likelyunavoidableclinicalscenarioduringtreatmentforvenousthromboembolismcomplicatedwithsevereimmunethrombocytopeniaacasereport
AT atsumitatsuya likelyunavoidableclinicalscenarioduringtreatmentforvenousthromboembolismcomplicatedwithsevereimmunethrombocytopeniaacasereport
AT kitamurakazuo likelyunavoidableclinicalscenarioduringtreatmentforvenousthromboembolismcomplicatedwithsevereimmunethrombocytopeniaacasereport